nadroparin calcium aspen 7,600 i.u. anti-xa/ 0.8 ml solution for injection in a pre-filled syringe
aspen pharma trading limited - nadroparin calcium - solution for injection - 7,600 i.u. anti-xa/ 0.8 millilitre(s) - heparin group; nadroparin
nadroparin calcium aspen 9,500 i.u. anti-xa/ 1.0 ml solution for injection in a vial
aspen pharma trading limited - nadroparin calcium - solution for injection - 9,500 i.u. anti-xa/1.0 millilitre(s) - heparin group; nadroparin
nadroparin calcium aspen 9,500 i.u. anti-xa/ 1.0 ml solution for injection in a vial
aspen pharma trading limited - nadroparin calcium - solution for injection - 9,500 i.u.anti-xa/1.0 millilitre(s) - heparin group; nadroparin
co-trimoxazole 80mg/400mg tablets
aspen pharma trading limited - sulfamethoxazole/trimethoprim - tablets - 80mg/400mg - combinations of sulfonamides and trimethoprim, incl. derivatives - it indicated for: treatment and prevention of pneumocystis jiroveci (p. carinii) pneumonitis; treatment and prophylaxis of toxoplasmosis; treatment of nocardiosis; acute uncomplicated urinary tract infection; acute otitis media; acute exacerbation of chronic bronchitis
co-trimoxazole 800mg/160mg forte tablets
aspen pharma trading limited - sulfamethoxazole/trimethoprim - tablets - 800mg/160mg - combinations of sulfonamides and trimethoprim, incl. derivatives - it is indicated for: treatment and prevention of pneumocystis jiroveci (p. carinii) pneumonitis; treatment and prophylaxis of toxoplasmosis; treatment of nocardiosis; acute uncomplicated urinary tract infection; acute otitis media; acute exacerbation of chronic bronchitis
co-trimoxazole 40mg/200mg per 5ml paediatric suspension
aspen pharma trading limited - sulfamethoxazole/trimethoprim - suspension - 40mg/200mg per 5ml - combinations of sulfonamides and trimethoprim, incl. derivatives - it is indicated for: treatment and prevention of pneumocystis jiroveci (p. carinii) pneumonitis treatment and prophylaxis of toxoplasmosis treatment of nocardiosis acute uncomplicated urinary tract infection acute otitis media acute exacerbation of chronic bronchitis
co-trimoxazole 80mg/400 mg per 5 ml adult suspension
aspen pharma trading limited - sulfamethoxazole/trimethoprim - suspension - 80mg/400 mg per 5 ml - combinations of sulfonamides and trimethoprim, incl. derivatives - it is indicated for: treatment and prevention of pneumocystis jiroveci.(p. carinii) pneumonitis; treatment and prophylaxis of toxoplasmosis; treatment of nocardiosis; acute uncomplicated urinary tract infections; acute otitis media; acute exacerbation of chronic bronchitis
fondaparinux sodium aspen 1.5 mg/0.3 ml solution for injection, pre-filled syringe
aspen pharma trading limited - fondaparinux sodium - solution for injection - fondaparinux
fondaparinux sodium aspen 2.5 mg/0.5 ml solution for injection, pre-filled syringe.
aspen pharma trading limited - fondaparinux sodium - solution for injection - fondaparinux
fludrocortisone acetate 0.1 mg tablets
aspen pharma trading limited - fludrocortisone acetate - tablet - 0.1 milligram(s) - mineralocorticoids; fludrocortisone - for partial replacement therapy for primary adrenocortical insufficiency in addison’s disease and for the treatment of salt-losing adrenogenital syndrome.